Evolva logo

Evolva

Recent Finacing

Equity

Recent Raise

Undisclosed

Swiss biotech using a genetic-chemistry platform to develop small-molecule drug candidates, runs discovery partnerships, and advances clinical compounds toward Phase II with operations in Basel, Denmark, USA, and India.

Founded 2004
Aargau, Switzerland
51-100
Publicly Traded
evolva.com

Highlights

Focus Areas

Biotechnology
Food and Beverage
Health Care
Wellness

Recent Investors

Financials

$39.5M

Total Raised

3

Funding rounds

7

Investors


Team

Upgrade to view the team

See the team members at Evolva.